BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29467021)

  • 1. Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection.
    Vasileva H; Butcher R; Pickering H; Sokana O; Jack K; Solomon AW; Holland MJ; Roberts CH
    Parasit Vectors; 2018 Feb; 11(1):104. PubMed ID: 29467021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands.
    Butcher RM; Sokana O; Jack K; Macleod CK; Marks ME; Kalae E; Sui L; Russell C; Tutill HJ; Williams RJ; Breuer J; Willis R; Le Mesurier RT; Mabey DC; Solomon AW; Roberts CH
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004863. PubMed ID: 27603015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project.
    Sokana O; Macleod C; Jack K; Butcher R; Marks M; Willis R; Chu BK; Posala C; Solomon AW
    Ophthalmic Epidemiol; 2016; 23(sup1):15-21. PubMed ID: 27937043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection.
    Derrick T; Last AR; Burr SE; Roberts CH; Nabicassa M; Cassama E; Bailey RL; Mabey DC; Burton MJ; Holland MJ
    BMC Infect Dis; 2016 Feb; 16():60. PubMed ID: 26842862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular
    Ramadhani AM; Derrick T; Macleod D; Massae P; Mtuy T; Jeffries D; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
    Front Cell Infect Microbiol; 2017; 7():406. PubMed ID: 28966918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?
    Faal N; Bailey RL; Jeffries D; Joof H; Sarr I; Laye M; Mabey DC; Holland MJ
    PLoS Med; 2006 Aug; 3(8):e266. PubMed ID: 16881731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea.
    Macleod CK; Butcher R; Javati S; Gwyn S; Jonduo M; Abdad MY; Roberts CH; Keys D; Koim SP; Ko R; Garap J; Pahau D; Houinei W; Martin DL; Pomat WS; Solomon AW
    Clin Infect Dis; 2021 Feb; 72(3):423-430. PubMed ID: 31965155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?
    Derrick T; Holland MJ; Cassama E; Markham-David R; Nabicassa M; Marks M; Bailey RL; Last AR
    Parasit Vectors; 2016 Jan; 9():30. PubMed ID: 26812948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
    Cama A; Müller A; Taoaba R; Butcher RMR; Itibita I; Migchelsen SJ; Kiauea T; Pickering H; Willis R; Roberts CH; Bakhtiari A; Le Mesurier RT; Alexander NDE; Martin DL; Tekeraoi R; Solomon AW;
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease.
    Skwor TA; Atik B; Kandel RP; Adhikari HK; Sharma B; Dean D
    PLoS Negl Trop Dis; 2008 Jul; 2(7):e264. PubMed ID: 18628987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection.
    Natividad A; Freeman TC; Jeffries D; Burton MJ; Mabey DC; Bailey RL; Holland MJ
    Infect Immun; 2010 Nov; 78(11):4895-911. PubMed ID: 20823212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assessment of conjunctival specimens for detection of Chlamydia trachomatis by PCR in children with active trachoma.
    de Barbeyrac B; Goldschmidt P; Malembic S; Raherison S; Clerc M; Bodaghi B; Bébéar C; Chaumeil C
    Clin Microbiol Infect; 2007 Jul; 13(7):689-94. PubMed ID: 17441975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
    Last AR; Burr SE; Weiss HA; Harding-Esch EM; Cassama E; Nabicassa M; Mabey DC; Holland MJ; Bailey RL
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2900. PubMed ID: 24967629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
    Burton MJ; Holland MJ; Faal N; Aryee EA; Alexander ND; Bah M; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.
    Ramadhani AM; Derrick T; Macleod D; Holland MJ; Burton MJ
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005080. PubMed ID: 27783678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
    Harding-Esch EM; Edwards T; Sillah A; Sarr I; Roberts CH; Snell P; Aryee E; Molina S; Holland MJ; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e573. PubMed ID: 20027217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
    Pickering H; Ramadhani AM; Massae P; Mafuru E; Malisa A; Mbuya K; Makupa W; Mtuy T; Derrick T; Houghton J; Bailey RL; Mabey DCW; Burton MJ; Holland MJ
    Front Public Health; 2022; 10():1015714. PubMed ID: 36324475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of Chlamydia trachomatis infection among mothers of children with trachoma.
    Brunham RC; Laga M; Simonsen JN; Cameron DW; Peeling R; McDowell J; Pamba H; Ndinya-Achola JO; Maitha G; Plummer FA
    Am J Epidemiol; 1990 Nov; 132(5):946-52. PubMed ID: 2239909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.